Endovascular femoropopliteal bypass: A cadaveric study  by Morris, G.E. et al.
Eur J Vasc Endovasc Surg 10, 9-15 (1995) 
Endovascular Femoropopliteal Bypass: A Cadaveric Study* 
G. E. Morris 1, S. S. Ahn 2, C. R. G. Quick 1, T. L. Kaiura 2 and V. A. Reger 3 
1Addenbrooke's Hospital, Cambridge, Cambs. U.K. and Royal South Hants Hospital, Southampton, Hants. U.K. 
2UCLA Center for the Health Sciences, Los Angeles, CA, U.S.A. and 3The Portland Cl ing Portland, Oregon, U.S.A. 
Objective: Patency rates of standard femoropopliteal bypass in infra-inguinal occlusive disease have yet to be matched by 
minimally invasive percutaneous procedures. We report a feasibility study of a less invasive ndovascular femoropopliteal 
bypass technique. 
Methods: (1) groin exposure of femoral artery, (2) guidewire passage and mechanical dilatation of superficial femoral artery 
(SFA), (3) expandable helical cutter endarterectomy of SFA, (4) transluminal placement of PTFE graft, (5) graft balloon 
dilatation to shape and set distal interface and (6) end-to-end anastomosis ofproximal graft to femoral artery. Development 
and testing was undertaken i  48 limbs of 26 fresh human cadavers. Limbs with no demonstrable SFA disease were 
excluded. Seventeen limbs had mild, diffuse disease. Three limbs had a single, short, tight stenosis. Seventeen limbs had 
multiple, high grade stenotic lesions 12-40 cm long (mean 24 cm). Eleven limbs had occlusive lesions, 8-38 cm long (mean 
24 cm). 
Results: We successfully completed the procedure in 39 (81%) limbs. We failed to complete the procedure in nine limbs; 
four from failed guidewire passage, four from vessel avulsion, and one from graft deployment failure. Histology confirmed 
endarterectomy cleavage in the standard plane. Angiography and explants demonstrated a patent graft and popliteal artery, 
and smooth distal graft~arterial nterface with no obvious defects in 24 (62%) cases. Defects included combinations of." 
contrast extravasation/reflux, graft malpositioned/incorrectly sized, distal graft folk and distal intimal flap. 
Conclusion: Endovascular femoropopliteal bypass is feasible and warrants further studies for possible clinical 
application. 
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Introduction 
The optimal treatment for patients suffering from 
intermittant claudication and superficial femoral 
artery occlusive disease has yet to be determined. 1 
Failure of any intervention may result in an acute or 
chronic deterioration in the limb, destabilising the 
condition and resulting in an increased risk of limb 
loss. As a result many surgeons have a high threshold 
for intervening in this relatively benign condition. 
At present, if intervention is undertaken, conven- 
tional femoro-popliteal bypass grafting offers the best 
medium and long-term benefits. Minimally invasive 
techniques, uch as balloon angioplast~ laser-assisted 
angioplasty and atherectomy have so far, not been 
able to match femoro-popliteal bypass grafting 5 year 
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patencies of up to 69% (PTFE), 75% (human umbilical 
vein) and 76% (reversed vein). 2-4 Patency with balloon 
angioplasty has been reported in the range of 27-53% 
at only 2 years, s'6 Laser angioplasty patency is similar 
7 at approximately 48% at 3 years. Atherectomy results 
are even lower, with approximately 19% patent at 2 
years. 8 Superficial femoral artery endarterectom~ 
although equalling bypass patency rates in some 
hands, requires two substantial incisions and cannot 
be defined as minimally invasive. Five-year patencies 
for the technique range from 36-71%. 9"1° 
If a less invasive reconstructive t chnique could be 
developed that gave patency rates comparable to, or 
better than, conventional femoro-popliteal bypass, 
there is a large cohort of potential patients that might 
benefit from intervention. In order to address this 
problem, we have evaluated and developed new 
devices (EndoVascular Instruments Inc.) enabling 
superficial femoral artery endarterectomy and trans- 
luminal femoro-popliteal grafting to be performed via 
a single small groin incision. This series of cadaveric 
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experiments has been completed to optimise method- 
ology prior to evaluating the technique in a limited 
animal and clinical study. 
Materials and Methods 
This study was undertaken concurrently at the 
Department of Human Pathology, Addenbrooke's 
Hospital, Cambridge, U.K. and the Department of 
SurgerN UCLA Medical Center, Los Angeles, U.S.A. 
We were given permission to use 26 cadavers for these 
experiments. Potential subjects were screened with 
bilateral direct femoral angiography before inclusion. 
Any cadaver with no evidence of disease in both 
superficial femoral arteries was excluded prior to the 
study. All cadavers had been stored for a maximum of 
5 days, at a temperature of 4 °C. Ages of the subjects 
ranged from 65-99 years with a mean of 82 years. 
Eighteen cadavers were female and eight were male. 
We used 48 limbs in the stud)5 having excluded four 
limbs immediately: two from no disease, and two 
from lack of time. 
Disease severity was scored by pre-selection angio- 
gram in the following categories: mild, diffuse (irregu- 
larity and some narrowing of lumen); single, high 
grade, discrete stenosis (greater than 75% lumen 
diameter); multiple, high grade, stenoses / diffuse 
disease (multiple lesions of equal to or greater than 
50% lumen diameter), and arterial occlusion. The 
disease severity and lesion length for the cohort 
studied is shown in Table 1. Real-time fluoroscopic 
imaging was used for all experiments. 
The technique for the procedure underwent a 
number of development modifications, and a final 
Table 1. Grades, frequency and extent of disease in limbs used in 
study 
Lesion length 
Number Range (cm) Mean (cm) 
Minimal disease 17 -- -- 
Single stenosis 3 1-1 1 
Multiple stenoses 17 12-40 24 
Occlusions 11 8-38 24 
protocol defined as follows: (1) Exposure of the 
femoral arteries in the groin, gaining control of inflow 
and outflow vessels; (2) Femoral arteriotomy and 
insertion of 5fr sheath, or 16 gauge AngioCath TM and 
passage of 0.035 guide wire to cross lesions(s) to below 
the knee (Figs I (a) and (b)); (3) Select desired location 
of distal interface and note it with marker; (4) 
Introduction and passage of rotating Dynamic Dila- 
tor TM (EndoVascular Instruments Inc. (EVI)): grad- 
uated sizes from 3-5 ram, across lesion(s) to marker 
(Fig. 2a); (5) 5 cm incremental passes of collapsed 
Helical Endarterectomy Catheter TM (EVI); catheter 
expanded and withdrawn to engage atheroma, retro- 
grade endarterectomy of SFA, in segments, to end 
point (Fig. 2b); (6) 6 mm balloon dilatation of end 
point; (7) Passage of peel-away sheath to end point 
(Fig. 3a); (8) Insertion of pre-loaded thin walled PTFE 
Goretex TM (WL Gore & Associates Ltd.) graft in peel- 
away sheath into previously positioned sheath to end 
point (Fig. 3b). Note: Thin-walled Goretex TM (WL Gore 
& Associates Ltd.) was chosen as preferred graft 
material following experiments with other PTFE 
prostheses which failed to pass easily through the 
sheath, and exhibited marked distal folding; (9) 
Sheaths removed, maintaining raft placement with 
Graft Inserter TM (EVI) (Fig. 4a); (10) Remove Graft 
(a) 
Arteriotomy site 
Superficial femoral 
Deep femoral 
Adductor canal 
-,'lJ ~ 
(b) 
Guide wire 
Fig. 1 (a) Arteriotomy of the superficial femoral rtery. (b) Insertion of an introducer sheath and passage ofthe guidewire across the lesion 
distally. 
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(a) 
(b) 
--% 
Fig. 2 (a) Mechanical dilatation of the diseased superficial femoral artery using the Dynamic Dilator TM. (b) Semi-closed endarterectomy 
using the Endarterectomy Catheter TM to engage atheroma. 
(a) 
(b) ~,~__~ ~ ~ ~ = ~ , ' ~  
Fig. 3 (a) Placement of a peel-away introducer sheath. (b) Placement ofthe graft hrough the introducer sheath and into the femoro-popliteal 
position by use of the Graft Inserter TM. The Graft Inserter TM pinches the graft near the distal end and lays over the folded graft. 
(a) 
_ _  .... 
(b) 
Fig. 4 (a) Removal of the peel-away sheath while holding the PTFE graft in place with the Graft Inserter TM. (b) Balloon dilatation of the 
graft. 
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Inserter TM (EVI); (11) Graft expanded, but not over 
distended, by incremental 6 mm balloon dilatations 
(Fig 4b); (12) Balloon dilatation of distal interface; (13) 
End to end anastomosis of proximal graft to femoral 
artery - -  not routinely completed in cadaveric study 
(Fig. 5); (14) Completion angiogram; (15) Casting of 
distal interface with dental moulding compound and 
explantation of specimen; (16) Formal histology of 
endarterectomy and explant specimens. The accept- 
able tolerances for distal graft/vessel interface control 
are shown in Fig. 6. 
Fig. 5. Completion ofthe standard end-to-end anastomosis of the 
proximal graft o the common femoral artery. 
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Step 6. Graft/balloon 
Fig. 6. Acceptable tolerances from the end point marker for distal 
graft/vessel interface control. 
Results 
The procedure was successfully completed in 39 limbs 
(81%). Four failures were guide wire related. Three of 
these were due to inability to cross the lesion 
satisfactorily with the guide wire - -  all in long 
occlusions starting at the origin of the superficial 
femoral artery. One experiment was aborted because 
of vessel perforation during guide wire positioning. In 
another case we were unable to pass the guide wire, 
but the procedure was completed satisfactorily by 
crossing the lesion with the Dynamic Guide Wire TM 
and then passing the guide wire through it. One 
incomplete procedure was due to an early graft 
delivery system failure. 
Vessel avulsion occurred in four limbs. Three of the 
cases had minimal disease and the oversized 15fr 
Endarterectomy Catheter TM was used, these cases 
were late in the series when we were evaluating the 
larger catheter. As a result we conclude that use of the 
larger catheter is contraindicated in the SFA. Also, in 
the clinical situation the procedure would not be 
attempted in a minimally diseased vessel. 
Fluoroscopy was performed routinely after endar- 
terectomy, and before graft placement. It showed 
complete ndarterectomy throughout the length of the 
traversed SFA in all cases with more than minimal 
disease. 
Totally satisfactory radiological and explanted spec- 
imen appearances were obtained in 24 of the 39 
completed procedures (62%). A satisfactory radio- 
graph, with subsequent good specimen appearance, is 
shown in Fig. 7. 
Abnormalities comprised combinations of: extrava- 
sation (proximal or distal), contrast reflux, graft 
inadequate l ngth, distal graft fold, graft too small and 
a distal intimal flap. An example of an angiogram with 
a distal fold and contrast reflux is shown in Fig. 8. The 
details of these defects are described in Table 2. 
Macroscopic observation of the endarterectomised 
specimens consistently revealed lengths of intact 
cores, corresponding in length to each Endarterectomy 
Catheter TM pass; piecemeal retrieval of disease was not 
a problem, except in the occasional minimally dis- 
eased artery. Histological examination of the endarter- 
ectomised specimens confirmed the presence of 
intima, with atheroma through to media in all cases 
- - the accepted endarterectomy plane. Explant sec- 
tions all revealed an intact adventitia with some 
media--again the accepted endarterectomy plane. 
The duration of the procedure was recorded in 28 
cases. Mean operating time was 81 min, with a range 
of 35-150 min. 
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Discussion 
The practice of endoluminal grafting via the femoral 
artery was first reported by Volodos' et al. in 1986. ~ 
The method has been developed, particularly for 
aneurysmal disease, with most experience at aortic 
sites, 12'a3 and some reports in the femoro-popliteal 
segment. 14-~6 All of these techniques use stents to fix 
and/or expand the graft. 
In all published cases of endovascular g aft implan- 
tation for occlusive disease, the arterial wall remained 
complete, although dilated by standard balloon tech- 
niques. There is a natural tendency for elastic recoil to 
occur in this situation, leading to potential graft 
compression and thus reocclusion. Cragg and Drake 
have attempted to reduce this by occasionally deploy- 
ing additional stents at the angioplasty sites, external 
to the graft, but this experience is limited. 14 With our 
novel technique of endarterectomy the risk is theoret- 
ically eliminated, resulting in a possibility for 
improved patency over previously described methods 
for treating occlusive disease. 
This study was designed to refine the techniques 
and equipment needed for endarterectomy and e o- 
luminal transaxial femoropopliteal bypass grafting, to 
a level of reproducibility acceptable for progression to 
a limited clinical series. It has been successful in this 
aim. Obviously no conclusions may be drawn as to 
patencies in the clinical situation. 
A number of important developments have been 
made and lessons learned, which have now brought 
us to the point of being confident o undertake the 
procedure in animal and clinical situations. Graft 
sizing is crucial. As the study progressed we used 
tapered PTFE grafts more commonlN as we were able 
to trim these to a more accurate distal diameter 
compatible with the distal vessel interface. The r sult 
was a reduction in contrast and moulding compound 
reflux, and a reduction in the presence of a distal graft 
fold. It is however, debatable, how haemodynamically 
Fig. 7. Completion angiogram showing a widely patent graft with 
no obvious defects. The arrow points to the distal graft/vessel 
interface. The bulldog clip is at the end of the distal balloon 
dilatation. Specimen mouldings and explant appearance also 
showed no defects. 
Fig. 8. Completion angiogram with a distal graft fold and contrast 
reflux due to use of an oversized graft. The arrow points to the distal 
graft/vessel interface. 
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Table 2. Range of defects recorded at experiment completion 
Number Position in Comments 
series 
Extravasation 
Proximal 8 4 early, 4 late Insignificant in 6 
cases - subsequent 
graft coverage 
Distal 3 2 early, I late All significant 
Contrast Reflux 3 2 early, i late Size mismatch 
Graft inadequate 3 All early Deployment 
length learning curve 
Distal graft fold 4 3 early, I late Size mismatch 
Graft too small 2 Both early Size mismatch 
Distal intimal flap 1 Late Significant 
A total of 15 cases exhibited combinations ofthe above abnormalities. 
Position in Series: 'early' indicates limb in first 20 cases, 'late' 
indicates limb in last 19 cases. 
significant a small distal fold would be in the clinical 
situation. 
Graft deployment techniques have undergone con- 
siderable modification. The pre-loading of the graft 
into a sheath and then positioning this via a second 
outer sheath, has been a significant advance in gaining 
good control of the distal interface. 
Sophisticated fluoroscopic imaging is mandatory, 
both to avoid guidewire mishaps and to ensure that 
the distal interface placement tolerances are main- 
tained. In the clinical situation we are including 
angioscopy in our experimental protocol, in order to 
directly assess the distal interface after endarter- 
ectomy, and on graft placement. 
The 15fr Helical Endarterectomy Catheter TM is too 
large for the SFA and should not be used. The 10fr 
catheter worked well and the endarterectomy separa- 
tion plane was consistently reproducible. The only 
vessel damage sustained with this catheter was when 
minimal disease was present - -  a contraindication to 
reconstruction a yway. 
All previously published methods of semi-closed 
endarterectomy have involved pushing Cannon (or 
modifications thereof) ring cutters along the artery, 
necessitating a further incision and arteriotomy to 
obtain a clean, undissected end-point. Our unique 
method of retrograde endarterectom)~ i.e. pulling back 
to engage the atheroma, results in a shelved, undis- 
sected istal interface. 
It might be suggested that with such a clean 
endarterectomy, graft placement is unnecessary. We 
would suggest that using a graft conveys three 
potential benefits. Firstly, femoro-popliteal endarter- 
ectomy has comparable patency to conventional graft- 
. 10 mg only in the best hands; therefore having a 
smooth graft lining over the roughened vessel outer 
media may improve patency, by limiting restenosis 
risks to the proximal and distal interfaces. Secondly, 
any small distal flap at risk of dissection is covered by 
graft. Finally, any mural perforations along the endar- 
terectomised segment are excluded from the circula- 
tion by the graft. 
Another debatable issue is our decision ot to stent 
the distal end of the graft. There is evidence that stents 
might encourage intimal growth at the site of place- 
ment. ~7 Currently available stents would also narrow 
further what is already asmall diameter graft. When a 
graft with an intrinsic intramural stent becomes 
available, this may offer an advantage. However, it 
should be noted that there is a reported risk of stent 
collapse with placement adjacent o the knee 14 - -  
obviated by having a flexible distal interface. There is 
some clinical and experimental evidence that lack of a 
distal graft stent in endovascular aortic aneurysm 
exclusion may result in reflux around the graft, and 
thus continued expansion of the aneurysm. 12'18 The 
aneurysrnal bdominal aorta has a highly elastic wall, 
and we believe a similar failure is unlikely to occur 
when treating a less elastic vessel for occlusive 
disease. No final answer to the question of distal 
stenting is possible until we have undertaken clinical 
studies. 
In conclusion, we feel this series of experiments has 
been sufficiently successful to justify animal and 
clinical studies of endarterectomy and endoluminal, 
transaxial femoropopliteal grafting. 
The technique has the potential to convey sig- 
nificant benefits in terms of a less invasive method and 
reduced hospital stay for patients requiring inter- 
vention for femoropopliteal occlusive disease. Admis- 
sion may be reduced to less than 24 h, with rapid 
remobilisation due to the limited dissection. 
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